A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis
Completed
Allergan
Phase 4
2011-10-01
This study will evaluate the duration of action of LASTACAFT® and Pataday™ as compared to
artificial tears (placebo) in the prevention of ocular itching associated with allergic
conjunctivitis.
A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis
Completed
Allergan
Phase 4
2012-11-01
This study will evaluate the efficacy of Lastacaft® (Alcaftadine 0.25%) and Pataday™
(Olopatadine 0.2%) as compared to each other and to placebo in the prevention of ocular
itching associated with allergic conjunctivitis.
To study the impact of alcaftadine in patients treated with other opthalmic ocular agents (or
specific topical opthalmic treatment) in an allergy subspecialist outpatient setting.
Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea
Completed
Allergan
2015-10-19
This post-marketing surveillance study will assess the safety and efficacy of Lastacaft®
Opthalmic Solution 0.25% (Alcaftadine) for the prevention of itching associated with Allergic
Conjunctivitis as prescribed as standard of care in clinical practice in Korea.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
